Jeff Sharman, MD of Willamette Valley Cancer Center discusses whether or not CAR T-cell therapy is promising for the treatment of non-hodgkin lymphoma. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Do CAR T-Cell therapies look promising for the treatment of NHL?
